Paul Lévesque

3.2k total citations
63 papers, 1.8k citations indexed

About

Paul Lévesque is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Paul Lévesque has authored 63 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 30 papers in Cardiology and Cardiovascular Medicine and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Paul Lévesque's work include Ion channel regulation and function (29 papers), Cardiac electrophysiology and arrhythmias (28 papers) and Neuroscience and Neuropharmacology Research (9 papers). Paul Lévesque is often cited by papers focused on Ion channel regulation and function (29 papers), Cardiac electrophysiology and arrhythmias (28 papers) and Neuroscience and Neuropharmacology Research (9 papers). Paul Lévesque collaborates with scholars based in United States, Germany and France. Paul Lévesque's co-authors include Joseph R. Hume, Mary Lee Conder, Michael A. Blanar, Wayne A. Little, Wen-Pin Yang, Fouad Shalaby, William D. Atchison, Burton Horowitz, James L. Kenyon and Normand Leblanc and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Paul Lévesque

62 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Lévesque United States 22 1.2k 831 596 205 195 63 1.8k
Kaichiro Kamiya Japan 32 2.1k 1.8× 2.3k 2.7× 603 1.0× 98 0.5× 78 0.4× 94 3.4k
Bruce P. Damiano United States 30 920 0.8× 646 0.8× 484 0.8× 74 0.4× 485 2.5× 72 2.7k
Heinrich Englert Germany 22 1.1k 0.9× 596 0.7× 439 0.7× 185 0.9× 41 0.2× 43 1.8k
Bryan F. Cox United States 27 1.0k 0.9× 702 0.8× 316 0.5× 82 0.4× 96 0.5× 85 1.8k
Ahmed Ahidouch France 25 1.2k 1.0× 198 0.2× 308 0.5× 75 0.4× 130 0.7× 34 1.9k
Julie Bossuyt United States 34 2.2k 1.8× 1.6k 1.9× 367 0.6× 61 0.3× 44 0.2× 77 2.8k
Ilona Bódi United States 24 1.7k 1.5× 1.2k 1.5× 523 0.9× 42 0.2× 28 0.1× 46 2.2k
Valeriy Timofeyev United States 20 1.1k 0.9× 1.0k 1.2× 311 0.5× 26 0.1× 63 0.3× 38 1.9k
Jeffrey R. Erickson New Zealand 21 1.6k 1.4× 1.2k 1.5× 227 0.4× 55 0.3× 129 0.7× 39 2.4k

Countries citing papers authored by Paul Lévesque

Since Specialization
Citations

This map shows the geographic impact of Paul Lévesque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Lévesque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Lévesque more than expected).

Fields of papers citing papers by Paul Lévesque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Lévesque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Lévesque. The network helps show where Paul Lévesque may publish in the future.

Co-authorship network of co-authors of Paul Lévesque

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Lévesque. A scholar is included among the top collaborators of Paul Lévesque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Lévesque. Paul Lévesque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roberts, Ruth, et al.. (2023). An integrated approach for early in vitro seizure prediction utilizing hiPSC neurons and human ion channel assays. Toxicological Sciences. 196(1). 126–140. 6 indexed citations
2.
Dai, Yan‐Shan, Uma Kavita, Margit H. Lampen, et al.. (2021). Prevalence of Pre-Existing Neutralizing Antibodies Against Adeno-Associated Virus Serotypes 1, 2, 5, 6, 8, and 9 in Sera of Different Pig Strains. Human Gene Therapy. 33(7-8). 451–459. 10 indexed citations
3.
Kavita, Uma, Yan‐Shan Dai, Lisa Salvador, et al.. (2018). Development of a Chemiluminescent ELISA Method for the Detection of Total Anti-Adeno Associated Virus Serotype 9 (AAV9) Antibodies. Human Gene Therapy Methods. 29(6). 237–250. 18 indexed citations
4.
Fan, Jing‐Song, George Thalody, Jae Kwagh, et al.. (2018). Assessing seizure liability using multi-electrode arrays (MEA). Toxicology in Vitro. 55. 93–100. 37 indexed citations
5.
Benjamin, Amanda, David J. Gallacher, Andrea Greiter‐Wilke, et al.. (2015). Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies. Journal of Pharmacological and Toxicological Methods. 75. 101–110. 4 indexed citations
6.
Finlay, Heather J., Ji Jiang, Mary Lee Conder, et al.. (2013). Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists. Bioorganic & Medicinal Chemistry Letters. 23(6). 1743–1747. 9 indexed citations
7.
Quang, Khaï Le, Patrice Naud, Xiaoyan Qi, et al.. (2011). Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice. Cardiovascular Research. 91(3). 420–428. 16 indexed citations
8.
Wang, Wei, Pratik Devasthale, Aiying Wang, et al.. (2011). 7-Oxopyrrolopyridine-derived DPP4 inhibitors—mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site. Bioorganic & Medicinal Chemistry Letters. 21(22). 6646–6651. 15 indexed citations
9.
Foster, William R., Bruce D. Car, Hong Shi, et al.. (2010). Drug safety is a barrier to the discovery and development of new androgen receptor antagonists. The Prostate. 71(5). 480–488. 92 indexed citations
10.
Sun, Huabin, et al.. (2009). Abstract 2515: A Selective IKur Blocker, BMS-394136 Selectively Prolongs Atrial APD and Refractoriness in Beagles and Rabbits. Circulation. 120. 1 indexed citations
11.
Sun, Hsin‐Yun, et al.. (2009). Antiarrhythmic Drug Therapy for Atrial Fibrillation: Focus on Atrial Selectivity and Safety. Cardiovascular & Hematological Agents in Medicinal Chemistry. 7(1). 64–75. 21 indexed citations
12.
Lloyd, John, Heather J. Finlay, Karnail S. Atwal, et al.. (2009). Dihydropyrazolopyrimidines containing benzimidazoles as KV1.5 potassium channel antagonists. Bioorganic & Medicinal Chemistry Letters. 19(18). 5469–5473. 35 indexed citations
13.
Johnson, Stephen R., Hongwen Yue, Mary Lee Conder, et al.. (2007). Estimation of hERG inhibition of drug candidates using multivariate property and pharmacophore SAR. Bioorganic & Medicinal Chemistry. 15(18). 6182–6192. 20 indexed citations
14.
Lloyd, John, Karnail S. Atwal, Heather J. Finlay, et al.. (2007). Benzopyran sulfonamides as KV1.5 potassium channel blockers. Bioorganic & Medicinal Chemistry Letters. 17(12). 3271–3275. 27 indexed citations
15.
Hangeland, Jon J., Daniel L. Cheney, Paul Lévesque, et al.. (2007). Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core. Bioorganic & Medicinal Chemistry Letters. 18(2). 474–478. 11 indexed citations
16.
Lee, Ning, Jian Chen, Lucy Sun, et al.. (2003). Expression and Characterization of Human Transient Receptor Potential Melastatin 3 (hTRPM3). Journal of Biological Chemistry. 278(23). 20890–20897. 170 indexed citations
17.
Yang, Wen-Pin, Paul Lévesque, Wayne A. Little, et al.. (1998). Functional Expression of Two KvLQT1-related Potassium Channels Responsible for an Inherited Idiopathic Epilepsy. Journal of Biological Chemistry. 273(31). 19419–19423. 168 indexed citations
18.
Lévesque, Paul, Normand Leblanc, & Joseph R. Hume. (1994). Release of calcium from guinea pig cardiac sarcoplasmic reticulum induced by sodium-calcium exchange. Cardiovascular Research. 28(3). 370–378. 60 indexed citations
19.
Lévesque, Paul, Michael F. Hare, & William D. Atchison. (1992). Inhibition of mitochondrial Ca2+ release diminishes the effectiveness of methyl mercury to release acetylcholine from synaptosomes. Toxicology and Applied Pharmacology. 115(1). 11–20. 15 indexed citations
20.
Lévesque, Paul, Normand Leblanc, & Joseph R. Hume. (1991). Role of Reverse‐Mode Na+‐Ca2+ Exchange in Excitation‐Contraction Coupling in the Hearta. Annals of the New York Academy of Sciences. 639(1). 386–397. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaichiro Kamiya Breakdown of academic impact, for papers by Bruce P. Damiano Breakdown of academic impact, for papers by Heinrich Englert Breakdown of academic impact, for papers by Bryan F. Cox Breakdown of academic impact, for papers by Ahmed Ahidouch Breakdown of academic impact, for papers by Julie Bossuyt Breakdown of academic impact, for papers by Ilona Bódi Breakdown of academic impact, for papers by Valeriy Timofeyev Breakdown of academic impact, for papers by Jeffrey R. Erickson
Rankless by CCL
2026